ANTITUMOR ACTIVITY OF C-MYC INHIBITOR KSI-3716 IN A GEMCITABINE-RESISTANT BLADDER CANCER

被引：1
|
作者：
Seo, Ho Kyung
Kwon, Whi-An
Sohn, Dong Wan
Son, Jeong Hwan
Park, Weon Seo
Lee, Kang-Hyun
Lee, Sang-Jin
Jeong, Kyung-Chae
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.843
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP21-15
引用
收藏
页码：E231 / E231
页数：1
相关论文
共 50 条
  • [1] Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
    Seo, Ho Kyung
    Ahn, Kyung-Ohk
    Jung, Nae-Rae
    Shin, Ji-Sun
    Park, Weon Seo
    Lee, Kang Hyun
    Lee, Sang-Jin
    Jeong, Kyung-Chae
    ONCOTARGET, 2014, 5 (02) : 326 - 337
  • [2] SUPPRESSED ORTHOTOPIC BLADDER TUMOR GROWTH BY INTRAVESICAL INSTILLATION OF THE C-MYC INHIBITOR KSI-3716
    Seo, Ho Kyung
    Kim, Kyung-Tae
    Seo, Hye-Hyun
    Shin, Seung-Pil
    Ahn, Kyung-Ohk
    Ji, Min-Joo
    Kim, In-Hoo
    Jeong, Kyung-Chae
    Lee, Sang-Jin
    JOURNAL OF UROLOGY, 2013, 189 (04): : E241 - E242
  • [3] Intravesical Instillation of c-MYC Inhibitor KSI-3716 Suppresses Orthotopic Bladder Tumor Growth
    Jeong, Kyung-Chae
    Kim, Kyung-Tae
    Seo, Hye-Hyun
    Shin, Seung-Pil
    Ahn, Kyung-Ohk
    Ji, Min-Ju
    Park, Weon Seo
    Kim, In-Hoo
    Lee, Sang-Jin
    Seo, Ho Kyung
    JOURNAL OF UROLOGY, 2014, 191 (02): : 510 - 518
  • [4] Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer
    Huang, Yen Ta
    Cheng, Chuan Chu
    Chiu, Ted H.
    Lai, Pei Chun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (05) : 1711 - 1724
  • [5] Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer
    Bae, Eun Seo
    Hong, Junhwa
    Lim, Yijae
    Byun, Woong Sub
    Chun, Simin
    Hong, Suckchang
    Lee, Sang Kook
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 14885 - 14911
  • [6] Development of replication-competent adenovirus for gemcitabine-resistant bladder cancer
    Jeong, N-R
    Seo, H-H
    Seo, H. K.
    Jung, Y. S.
    Lee, S-J
    HUMAN GENE THERAPY, 2013, 24 (12) : A157 - A157
  • [7] Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines
    Takezaki, Yuka
    Namikawa, Tsutomu
    Koyama, Tsuyoshi
    Munekage, Eri
    Munekage, Masaya
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Hanazaki, Kazuhiro
    ANTICANCER RESEARCH, 2016, 36 (11) : 6077 - 6082
  • [8] Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting EMT Gemcitabine Transporters
    Wu, Ying S.
    Ho, Jar Y.
    Yu, Cheng Y.
    Huang, Cheng S.
    Gao, Hong W.
    CANCER SCIENCE, 2024, 115 : 800 - 800
  • [9] Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
    Vallo S.
    Michaelis M.
    Gust K.M.
    Black P.C.
    Rothweiler F.
    Kvasnicka H.-M.
    Blaheta R.A.
    Brandt M.P.
    Wezel F.
    Haferkamp A.
    Cinatl J., Jr.
    BMC Research Notes, 9 (1)
  • [10] c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer
    Li, Yiqi
    Li, Xinru
    Pu, Jun
    Yang, Qi
    Guan, Haixia
    Ji, Meiju
    Shi, Bingyin
    Chen, Mingwei
    Hou, Peng
    THYROID, 2018, 28 (12) : 1642 - 1654
12345